Your contribution supports the pre-clinical work required before a ECHS1 Deficiency clinical trial becomes feasible.
This work includes pre-clinical research to develop an ECHS1 Deficiency gene therapy, creation and manufacture of an AAV/ECHS1 vector, and testing the safety and efficacy of AAV/ECHS1 in both cell models and mice.
Thank you, you are advancing the future of medicine at UT Southwestern and we are grateful for your support!
Learn more about ECHS1 pre-clinical research at UTSW here.
UT Southwestern Medical CenterOffice of Development & Alumni RelationsP.O. Box 910888Dallas, TX 75391-0888Memo: ECHS1
To make a gift by EFT, ACH, or an International funds transfer please contact: giving@utsouthwestern.edu
If your corporation or employer matches your charitable contributions, contact us directly for information: UTSWMatchingGifts